Camurus - Public Comps and Valuation Multiples

Camurus Overview

About Camurus

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus’ clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Founded

2004

HQ

Employees

256

Website

camurus.com

Sectors

Drug Development & Therapeutics
Drug Delivery Systems
BioTech

Financials

LTM Revenue $256M

LTM EBITDA $103M

EV

$3.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Camurus Financials

As of September 2025, Camurus reported last 12-month revenue of $256M and EBITDA of $103M.

In the same period, Camurus generated $240M in LTM gross profit and $88.2M in net income.

See Camurus valuation multiples based on analyst estimates

Camurus P&L

In the most recent fiscal year, Camurus reported revenue of $196M and EBITDA of $59.8M.

Camurus expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Camurus valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$256M	XXX	$196M	XXX	XXX	XXX
Gross Profit	$240M	XXX	$183M	XXX	XXX	XXX
Gross Margin	94%	XXX	93%	XXX	XXX	XXX
EBITDA	$103M	XXX	$59.8M	XXX	XXX	XXX
EBITDA Margin	40%	XXX	30%	XXX	XXX	XXX
EBIT	$98.1M	XXX	$48.8M	XXX	XXX	XXX
EBIT Margin	38%	XXX	25%	XXX	XXX	XXX
Net Profit	$88.2M	XXX	$45.1M	XXX	XXX	XXX
Net Margin	34%	XXX	23%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Camurus including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $256M. EBITDA for the last twelve months was $103M. In the most recent fiscal year, Camurus achieved $196M in revenue and $59.8M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$256M	Analyst estimates available to subscribers	$196M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$240M	Analyst estimates available to subscribers	$183M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	93.7% gross margin	Analyst estimates available to subscribers	93.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$103M	Analyst estimates available to subscribers	$59.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	40.1% EBITDA margin	Analyst estimates available to subscribers	30.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$98.1M	Analyst estimates available to subscribers	$48.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	38.3% EBIT margin	Analyst estimates available to subscribers	24.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$88.2M	Analyst estimates available to subscribers	$45.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	34.4% net profit margin	Analyst estimates available to subscribers	22.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Camurus

This financial data table provides comprehensive performance metrics for Camurus, a company based in Sweden. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Camurus generated $256M in revenue over the last twelve months.
The company achieved $103M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $240M.
Net income over the last twelve months reached $88.2M.

Fiscal Year Performance

In the most recent fiscal year, Camurus reported $196M in total revenue.
Fiscal year EBITDA was $59.8M.
The company maintained a gross profit margin of 93.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 30.4%.
Net profit margin reached 22.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Camurus. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Camurus Stock Performance

Camurus has current market cap of SEK 39.7B (or $4.2B), and EV of SEK 36.5B (or $3.8B).

Market Cap Evolution

Camurus Stock Data

As of October 17, 2025, Camurus's stock price is SEK 666 (or $70).

See Camurus trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.8B	$4.2B	XXX	XXX	XXX	XXX	$1.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Camurus Valuation Multiples

Camurus's trades at 19.5x EV/Revenue multiple, and 64.2x EV/EBITDA.

See valuation multiples for Camurus and 15K+ public comps

Camurus Financial Valuation Multiples

As of October 17, 2025, Camurus has market cap of $4.2B and EV of $3.8B.

Equity research analysts estimate Camurus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Camurus has a P/E ratio of 47.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$4.2B	XXX	$4.2B	XXX	XXX	XXX
EV (current)	$3.8B	XXX	$3.8B	XXX	XXX	XXX
EV/Revenue	15.0x	XXX	19.5x	XXX	XXX	XXX
EV/EBITDA	37.3x	XXX	64.2x	XXX	XXX	XXX
EV/EBIT	39.1x	XXX	78.6x	XXX	XXX	XXX
EV/Gross Profit	16.0x	XXX	n/a	XXX	XXX	XXX
P/E	47.4x	XXX	92.7x	XXX	XXX	XXX
EV/FCF	54.5x	XXX	101.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Camurus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Camurus Margins & Growth Rates

Camurus's last 12 month revenue growth is 43%

Camurus's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.5M for the same period.

Camurus's rule of 40 is 76% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Camurus's rule of X is 147% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Camurus and other 15K+ public comps

Camurus Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	43%	XXX	41%	XXX	XXX	XXX
EBITDA Margin	40%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	66%	XXX	40%	XXX	XXX	XXX
Rule of 40	76%	XXX	73%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	147%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.8M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.5M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	26%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	37%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	68%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial